Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 4, 2006, Pages 877-883

  Naruko, Takahiko ^a   Ueda, Makiko ^b   Ehara, Shoichi ^b   Itoh, Akira ^a   Haze, Kazuo ^a   Shirai, Nobuyuki ^b   Ikura, Yoshihiro ^b   Ohsawa, Masahiko ^b   Itabe, Hiroyuki ^c   Kobayashi, Yoshiki ^b   Yamagishi, Hiroyuki ^b   Yoshiyama, Minoru ^b   Yoshikawa, Junichi ^b   Becker, Anton E ^d  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHOWA UNIVERSITY   (Japan)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute coronary syndromes; Coronary artery disease; Lipoproteins; Restenosis; Stent

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OXIDIZED LOW DENSITY LIPOPROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CORONARY STENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STENOSIS; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; CORONARY RESTENOSIS; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; STENTS;

EID: 33646693817     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000209886.31510.7f     Document Type: Article

References (17)

1. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
2. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
3. Holvoet P, Stassen JM, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18:100-107.
4. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998;98:1487-1494.
5. Itabe H, Yamamoto H, Imanaka T, Shimamura K, Uchiyama H, Kimura J, Sanaka T, Hata Y, Takano T. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res. 1996;37:45-53.
6. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Elevated levels of oxidized low density lipoproteinshow a positive relationship with the severity of acute coronary syndromes. Circulation. 2001;103:1955-1960.
7. Kayo S, Ohsawa M, Ehara S, Naruko T, Ikura Y, Hai E, Yoshimi N, Shirai N, Tsukamoto Y, Itabe H, Higuchi K, Arakawa T, Ueda M. Oxidized low density lipoprotein levels circulating in plasma and deposited in the tissues: comparison between Helicobacter pylori-associated gastritis and acute myocardial infarction. Am Heart J. 2004;148:818-825.
8. Wu R, de Faire U, Lemne C, Witztum JL, Frostegard J. Autoantibodies to OxLDL are decreased in individuals with borderline hypertension. Hypertension. 1999;33:53-59.
9. Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witztum JL. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol. 2003;41:360-370.
10. Van Berkel TJ, De Rijke YB, Kruijt JK. Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J Biol Chem. 1991;266:2282-2289.
11. Uno M, Kitazato KT, Nishi K, Itabe H, Nagahiro S. Raised plasma oxidized LDL in acute cerebral infarction. J Neurol Neurosurg Psychiatry. 2003;74:312-316.
12. Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation. 1998;98:224-233.
13. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol. 2000;35:157-163.
14. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation. 2002;105:2974-2980.
15. Stiko-Rahm A, Hultgardh-Nilsson A, Regnstrom J, Hamsten A, Nilsson J. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler Thromb. 1992;12:1099-1109.
16. Itabe H, Mori M, Fujimoto Y, Higashi Y, Takano T. Minimally modified LDL is an oxidized LDL enriched with oxidized phosphatidylcholines. J Biochem. 2003;134:459-465.
17. Kinjo K, Sato H, Nakatani D, Mizuno H, Shimizu M, Hishida E, Ezumi A, Hoshida S, Koretsune Y, Hori M. Osaka Acute Coronary Insufficiency Study (OACIS) Group. Predictors of length of hospital stay after acute myocardial infarction in Japan. Circ J. 2004;68:809-815.